Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H O Hallander

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Journal of Clinical Microbiology|January 1, 1993
Comparison of nasopharyngeal aspirates with swabs for culture of Bordetella pertussisH O Hallander, E Reizenstein, B Renemar, et al.
Journal of Immunological Methods|June 28, 1995
Comparison of five calculation modes for antibody ELISA procedures using pertussis serology as a modelE Reizenstein, H O Hallander, W C Blackwelder, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1990
Female urinary tract infection in primary health care: bacteriological and clinical characteristicsE Osterberg, H O Hallander, A Kallner, et al.
Journal of Microbiological Methods|July 7, 2009
Analysis of Swedish Bordetella pertussis isolates with three typing methods: characterization of an epidemic lineageA Advani, H G J Van der Heide, H O Hallander, et al.
Vaccine|March 10, 1998
Catch-up primary vaccination with acellular pertussis vaccines in 3-4-year-old children--reactogenicity and serological responseO Wärngård, L Nilsson, C Fåhraeus, et al.
Vaccine|November 22, 2002
Calibrated serological techniques demonstrate significant different serum response rates to an oral killed cholera vaccine between Swedish and Nicaraguan childrenH O Hallander, M Paniagua, F Espinoza, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 1, 1995
Atypical mycobacteria in extrapulmonary disease among children. Incidence in Sweden from 1969 to 1990, related to changing BCG-vaccination coverageV Romanus, H O Hallander, P Wåhlén, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 8, 2000
Towards European urinalysis guidelines. Introduction of a project under European Confederation of Laboratory MedicineT T Kouri, V A Gant, G B Fogazzi, et al.
Vaccine|June 10, 2015
Two consecutive randomized controlled pertussis booster trials in children initially vaccinated in infancy with an acellular vaccine: The first with a five-component Tdap vaccine to 5-year olds and the second with five- or monocomponent Tdap vaccines at age 14-15 yearsR M Carlsson, L Gustafsson, H O Hallander, et al.
Journal of Clinical Microbiology|June 16, 2005
Analysis of Bordetella pertussis populations in European countries with different vaccination policiesS C M van Amersfoorth, L M Schouls, H G J van der Heide, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Journal of Clinical Microbiology|January 1, 1993
Comparison of nasopharyngeal aspirates with swabs for culture of Bordetella pertussisH O Hallander, E Reizenstein, B Renemar, et al.
Journal of Immunological Methods|June 28, 1995
Comparison of five calculation modes for antibody ELISA procedures using pertussis serology as a modelE Reizenstein, H O Hallander, W C Blackwelder, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1990
Female urinary tract infection in primary health care: bacteriological and clinical characteristicsE Osterberg, H O Hallander, A Kallner, et al.
Journal of Microbiological Methods|July 7, 2009
Analysis of Swedish Bordetella pertussis isolates with three typing methods: characterization of an epidemic lineageA Advani, H G J Van der Heide, H O Hallander, et al.
Vaccine|March 10, 1998
Catch-up primary vaccination with acellular pertussis vaccines in 3-4-year-old children--reactogenicity and serological responseO Wärngård, L Nilsson, C Fåhraeus, et al.
Vaccine|November 22, 2002
Calibrated serological techniques demonstrate significant different serum response rates to an oral killed cholera vaccine between Swedish and Nicaraguan childrenH O Hallander, M Paniagua, F Espinoza, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 1, 1995
Atypical mycobacteria in extrapulmonary disease among children. Incidence in Sweden from 1969 to 1990, related to changing BCG-vaccination coverageV Romanus, H O Hallander, P Wåhlén, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 8, 2000
Towards European urinalysis guidelines. Introduction of a project under European Confederation of Laboratory MedicineT T Kouri, V A Gant, G B Fogazzi, et al.
Vaccine|June 10, 2015
Two consecutive randomized controlled pertussis booster trials in children initially vaccinated in infancy with an acellular vaccine: The first with a five-component Tdap vaccine to 5-year olds and the second with five- or monocomponent Tdap vaccines at age 14-15 yearsR M Carlsson, L Gustafsson, H O Hallander, et al.
Journal of Clinical Microbiology|June 16, 2005
Analysis of Bordetella pertussis populations in European countries with different vaccination policiesS C M van Amersfoorth, L M Schouls, H G J van der Heide, et al.
Pageof 7